Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study - Concepedia

Concepedia

Publication | Open Access

Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study

DOI Full Paper Access

108

Citations

28

References

2011

Year

Nathan Fowler, Brad S. Kahl, Peter P. Lee, Jeffrey Matous, Amanda F. Cashen, Samuel A. Jacobs, Jeffrey Letzer, Bipinkumar Amin, Michael E. Williams, Sonali M. Smith,

Journal of Clinical Oncology

Abstract

The combination of bortezomib, bendamustine, and rituximab is highly active in patients with follicular lymphoma who have received previous treatment.

References

	Year	Citations

Page 1